Literature DB >> 32092664

Epidemiology of pre-eclampsia in the Republic of Kazakhstan: Maternal and neonatal outcomes.

Gulnara T Nurgaliyeva1, Yuliya M Semenova2, Gulyash A Tanysheva2, Zhansulu E Akylzhanova3, Ion Bologan4, Gulshat K Manabayeva2.   

Abstract

BACKGROUND: Pre-eclampsia (PE) still significantly contributes to maternal and neonatal morbidity and mortality. This study aimed at evaluation of the prevalence of PE among Kazakhstani women and on elucidation of the associated maternal and neonatal outcomes.
METHODS: The study followed a retrospective cross-sectional design and was based on the data obtained from the electronic patient registry comprising health records of all patients hospitalized to maternal facilities of Kazakhstan over the period of one year. The diagnosis of PE was made on the basis of criteria established by International Society for the Study of Hypertension in Pregnancy.
RESULTS: Out of 2548 patients, 2408 (94.5%) were non-PE cases, while 54 (2.1%) were early-onset PE cases and 86 records (3.4%) were late-onset PE cases. Birth weight of children born from PE pregnancy was significantly lower in pregnancies complicated with early onset PE and constituted 1565 g. Postpartum hemorrhage was more prevalent in pregnancies complicated with PE.
CONCLUSION: The data obtained are needed to tailor public health interventions targeted on a reduction of PE problem in Kazakhstan.
Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. All rights reserved.

Entities:  

Keywords:  Hypertension; Kazakhstan; Maternal outcome; Neonatal outcome; Pre-eclampsia

Year:  2020        PMID: 32092664     DOI: 10.1016/j.preghy.2020.02.003

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  1 in total

1.  The association of hypertensive disorders of pregnancy with small for gestational age and intertwin birthweight discordance.

Authors:  Dongxin Lin; Caihong Luo Bd; Gengdong Chen; Dazhi Fan; Zheng Huang; Pengsheng Li; Shuzhen Wu; Shaoxin Ye Bd; Huiting Ma; Jiaming Rao; Huishan Zhang; Ting Chen; Meng Zeng; Xiaoling Guo; Zhengping Liu
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-20       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.